← Back to Search

CTU vs IVU Scans for Bladder Cancer

N/A

Waitlist Available

Led By Chaan Ng, MD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who had cystectomies for bladder cancer

Patients with upper tract TCC

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial will compare CTU and IVU scans in order to determine if CTU can be used effectively by itself to check the status of urothelial cancer.

Who is the study for?

This trial is for adults over 18 with confirmed urothelial cancer, including those who've had bladder tumors of Stage T3 or higher, cystectomies for bladder cancer, or upper tract TCC. Participants must consent and be referred for CTU as part of routine care. It's not suitable for individuals with high serum creatinine levels (>2), contrast media allergies, women who could become pregnant, or those who have had a ureteral stint placed or removed within six weeks.Check my eligibility

What is being tested?

The study compares the effectiveness of Computed Tomography Urography (CTU) versus Intravenous Urography (IVU) in evaluating urothelial cancers. The aim is to determine if CTU can be used alone to assess these cancers effectively in future patients.See study design

What are the potential side effects?

Potential side effects may include allergic reactions to the contrast media used during scans and kidney function impairment due to the substances injected into veins before imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had surgery to remove my bladder due to cancer.

Select...

I have cancer in the upper part of my urinary system.

Select...

My cancer is confirmed to be transitional cell carcinoma.

Select...

My bladder cancer is at an advanced stage.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CTU to IVU Technical Performance Comparison: Opacification + Ability to Visualize Urothelial Segments

Trial Design

1Treatment groups

Experimental Treatment

Group I: CTU + IVUExperimental Treatment2 Interventions

CTU = Computed Tomography Urography + IVU = Intravenous Urography

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,966 Previous Clinical Trials

1,804,648 Total Patients Enrolled

GE HealthcareIndustry Sponsor

289 Previous Clinical Trials

630,923 Total Patients Enrolled

Chaan Ng, MDPrincipal InvestigatorM.D. Anderson Cancer Center

2 Previous Clinical Trials

165 Total Patients Enrolled

Media Library

Computed Tomography Urography (CTU) Clinical Trial Eligibility Overview. Trial Name: NCT00567684 — N/A

Bladder Cancer Research Study Groups: CTU + IVU

Bladder Cancer Clinical Trial 2023: Computed Tomography Urography (CTU) Highlights & Side Effects. Trial Name: NCT00567684 — N/A

Computed Tomography Urography (CTU) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00567684 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are volunteers still being sought to participate in this clinical experiment?

"According to data hosted on clinicaltrials.gov, this trial is no longer recruiting candidates as the most recent update was November 10th 2022. Despite the cessation of recruitment for this particular medical study, there are presently 373 other trials actively searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

2007. "Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00567684.